EXPEDEON AG Inactive Instrument
Expedeon AG Share Price Deutsche Boerse AG
Equities
Investment Holding Companies
| Sales 2022 | 3.01M 3.24M 259M | Sales 2023 | 9M 9.7M 775M | Capitalization | 42.82M 46.12M 3.68B |
|---|---|---|---|---|---|
| Net income 2022 | -21M -22.62M -1.81B | Net income 2023 | 1M 1.08M 86.04M | EV / Sales 2022 | 11.1 x |
| Net cash position 2022 | 17.42M 18.76M 1.5B | Net cash position 2023 | 14.73M 15.86M 1.27B | EV / Sales 2023 | 3.12 x |
| P/E ratio 2022 |
-2.42
x | P/E ratio 2023 |
27.2
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 19.23% |
More Fundamentals
* Assessed data
More news
More press releases
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 08/07/19 | |
Sebastian Paul
ADM | Chief Administrative Officer | - | 30/06/15 |
Robert Mayer
IRC | Investor Relations Contact | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 08/07/19 | |
Eva Katheder
BRD | Director/Board Member | - | 27/01/21 |
Jochen Hummel
BRD | Director/Board Member | 54 | 02/06/22 |
2Invest AG, formerly 4Basebio AG, is a Germany-based investment company. 2invest AG acquires, holds, manages and sells investments in corporations and partnership in the biotechnology, life science and information technologies (IT) sectors in Germany and abroad.
Sector
Investment Holding Companies
Calendar
13/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +21.08% | 79.58B | |
| +67.28% | 18.68B | |
| +10.98% | 17.17B | |
| +10.92% | 14.54B | |
| +3.79% | 13.02B | |
| +9.14% | 12.08B | |
| +9.87% | 11.23B | |
| +39.26% | 10.55B | |
| -0.80% | 9.82B |
